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COMMENT ON THE GLOBAL GAMING
INDUSTRY’S STATEMENT ON ICD-11 GAMING
DISORDER: A CORPORATE STRATEGY TO
DISREGARD HARM AND DEFLECT SOCIAL
RESPONSIBILITY?
Following the announcement that gaming disorder (GD)
will be included in the World Health Organization’s
(WHO) International Classiﬁcation of Diseases (ICD-11)
[1], multiple gaming industry organizations (henceforth
‘the industry’) have issued a statement in opposition to
GD [2]. The industry advances several arguments, includ-
ing the notions that: gaming is predominantly enjoyed
‘safely and sensibly’; gaming has various personal beneﬁts;
theGD evidence base is ‘highly contested and inconclusive’;
and GD would create moral panic and ‘abuse of diagnosis’.
We believe that, regardless ofwhether GD is embraced byall
researchers, arguments highlighting the popularity and
beneﬁts of gaming and disputing GD should not enable
the industry to ignore the global evidence of gaming-related
harms. The industry statement does not recognize clinical
and public health needs and evidence identifying the ad-
verse impacts of problematic gaming (e.g. social isolation,
displaced sleep, physical inactivity and dietary problems,
decreased psychological wellbeing, academic or job inter-
ference and interpersonal conﬂicts) [3,4]. Instead, the in-
dustry could reﬂect upon its strong capabilities to protect
vulnerable consumers and its share of responsibility for
the reduction of gaming-related harms [5].
Corporate strategy refers broadly to a company’s pat-
tern of decisions that determines its goals and plans [6].
The gaming industry’s corporate strategy involves the
pursuit of economic gain from gaming products and
services. This strategy is aided by promoting the view that
all gaming, without exception, enhances people’s quality of
life. The industry’s statement demonstrates this by: (1)
extolling the value and popularity of gaming in absolute
terms, without any comment on the risks or harms associ-
ated with excessive gaming involvement; (2) drawing
a false equivalence between the beneﬁts of educational
software and commercial video games in general and
ignoring research evidence that ﬁnds certain beneﬁts to
be negligible [7]; and (3) selectively referring to academics
who appear to support the industry’s position while
ignoring these same authors’ acknowledgement in the
quoted article that ‘there are some people whose play of
video games is related to life problems’ [8].
The industry is encouraged to recognize the important
epidemiological [9–14], neurobiological [15,16] and clini-
cal [17,18] evidence on problematic gaming. Although
there is healthy discussion concerning the
conceptualization of problematic gaming as a disorder,
gaming-related harm is acknowledged by many who op-
pose the concept of GD [8], and academic debates should
not bemisused to support the notion that gaming is always
innocuous. The industry should recognize that its business
model, despite its many successes, has ethical and social
responsibilities. Gaming can enrich people’s lives, but it
can also have adverse impacts and generate harms among
vulnerable individuals and their families. As with any
product which attracts a disproportionate volume of usage
and revenue from a minority of consumers, the industry is
encouraged to adopt an approach that minimizes harm
and consistently involves responsible practices [19].
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Acknowledging gaming-related harms will promote more
ethical game design standards and business practices, as
well as other organized and collaborative efforts to
respond to the needs of problematic users.
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